Novo Nordisk
Jul 11, 2026, 21:43
Sharing New Research in Hemophilia at ISTH 2026 – Novo Nordisk Medical US
Novo Nordisk Medical US shared a post on X:
“Heading to ISTH 2026 in Paris?
We look forward to sharing new research in hemophilia at the congress.
Here is a snapshot of our oral presentations. Feel free to stop by booth 907 to engage with the Novo Nordisk medical team.
Visit the ISTH congress program for more details.”
Proceed to the video attached to the post.
Stay Updated with ISTH 2026 on Hemostasis Today.
-
Jul 11, 2026, 21:41Bianca Constantin: Don’t Miss the ISTH Early Career Committee Activities
-
Jul 11, 2026, 21:38Fateme Babaha: Don’t Miss Your Favorite ISTH 2026 Sessions
-
Jul 11, 2026, 21:11Farjah Algahtani: Learning, Sharing, and Collaborating at ISTH 2026
-
Jul 11, 2026, 19:56Louise St. Germain Bannon: A Fantastic Start to ISTH 2026 and the Future of Thrombosis Research
-
Jul 11, 2026, 19:38Lynn Kloeckner: Recognizing Kirsten Lacine’s Impact on the Stroke Survivor Journey
-
Jul 11, 2026, 19:19Rens De Groot: New Proteomic Evidence Reveals Early Hemolysis During ADAMTS13 Relapse in Immune TTP
-
Jul 11, 2026, 19:01Laurent Bertoletti: Honoring the Legacy of Guy Meyer and the INNOVTE Network at ISTH 2026
-
Jul 11, 2026, 18:53Pilar de la Rocha Mur: Why Trust Is the Most Valuable Currency in Clinical Research
-
Jul 11, 2026, 18:25First Pathogenic Deep-Intronic SERPINC1 Variant Identified in Hereditary Antithrombin Deficiency – JTH